Syndax Pharmaceuticals

Syndax stops pivotal cancer trial early for efficacy but details disappoint, sending stock down
Fierce Biotech
Mon, 10/2/23 - 10:26 am
Syndax Pharmaceuticals
clinical trials
revumenib
AML
Biotech heads towards big catalysts
EP Vantage
Tue, 03/28/23 - 10:24 am
biotech
clinical trials
Alnylam Pharmaceuticals
Arcus Biosciences
Argenx
Arrowhead Pharmaceuticals
Axsome Therapeutics
Bavarian Nordic
FibroGen
Gilead Sciences
Incyte
Morphic Therapeutic
PTC Therapeutics
Syndax Pharmaceuticals
Travere Therapeutics
Vaxcyte